CYBB Overexpression in EAE Mice: Impacts on Neurological Factors and Inflammation
In a study involving EAE mice, researchers found that overexpression of CYBB significantly improved neurological scores and reversed pathological changes. This included reductions in inflammatory cytokines and oxidative stress indicators, along with the downregulation of proteins associated with pyroptosis.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
These findings suggest that CYBB could play a role in mitigating neurological damage and inflammation in multiple sclerosis models, potentially guiding future research on therapeutic strategies.
What this does not prove
The study does not establish the direct applicability of findings to human MS cases, as it is based on an animal model.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-09
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceEffects and mechanism of CYBB on the progression of multiple sclerosis: Evidence from bioinformatic analysis and experimental validation. ↗DOI: 10.1016/j.gene.2026.150441
Supporting passages (4)
primary endpointNeurological scores, inflammatory factors (tumor necrosis factor-α [TNF-α], interleukin-1β [IL-1β], interleukin-18 [IL-18], and monocyte chemoattractant protein-1 [MCP-1]), oxidative stress indicators (malondialdehyde [MDA], superoxide dismutase [SOD], and catalase [CAT]), pathological damage, and pyroptosis-related proteins (NOD-like receptor pyrin domain-containing 3 [NLRP3], apoptosis-associated speck-like protein containing a CARD [ASC], and Caspase-1) were evaluated.
findingsCYBB overexpression significantly reversed these pathological alterations, suppressed proinflammatory cytokines and oxidative stress, and prevented the upregulation of pyroptosis-related proteins.
publication datePublication date: 2026-10-09
limitationsTitle: Effects and mechanism of CYBB on the progression of multiple sclerosis: Evidence from bioinformatic analysis and experimental validation.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.